SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes in adults. It works by combining two active ingredients: ertugliflozin, which helps the kidneys remove excess glucose, and metformin, which reduces glucose production in the liver. This combination is often used when diet and exercise alone are not enough to control blood sugar levels. People may ask, 'What is Segluromet used for?' primarily to understand its role in diabetes management.

Common effects of Segluromet 7.5 mg/1 may include symptoms like urinary tract infections, nasal congestion, and diarrhea. Some individuals might experience low blood sugar, especially when combined with other diabetes medications. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Segluromet 7.5 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It's important to stay hydrated and avoid excessive alcohol consumption. Regular monitoring of blood sugar levels is recommended. Always follow the advice of a healthcare professional regarding its use.

Segluromet 7.5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can increase the risk of lactic acidosis, a serious side effect associated with metformin. It's important to discuss all current medications with a healthcare provider to avoid potential interactions.